Tuesday, November 9, 2010

The CHAMPION Penny Stock Aastrom Biosciences, Inc. (ASTM)

The CHAMPION Penny Stock for Thursday, October 28, 2010 is…

Aastrom Biosciences, Inc. (ASTM)
  • Last Trade: $2.17
  • Price changed: $0.3901
  • Percentage Gain: +21.92%
  • Prev Close: $1.78
  • Volume: 3,822,922
  • Dollar Volume: $8,296,123
Congrats to top stock picker: Penny Invest

You are the King of the Stock Pickers today!

About Penny Stock Rumble: http://www.pennystockrumble.com/

Our Investment Tool is easy to use. Just follow these steps and start seeing your financial portfolio going in the direction of green.
Steps to financial success:
  1. Sign up in the box at top of page. You will be emailed an activation link. Click on the link and your account is automatically setup and ready to go.
  2. Sign in!
  3. Once you sign in, you will be able to view all the top penny stock picks for the day. We input these by hand before the market opens.
  4. Sort the stocks by percentage change (by double clicking on the %change column) so that the top gainers are on top.
  5. You can also sort all of the penny stocks by $ Change/Last Price/Volume/Symbol/Company
  6. Check out which penny stock pickers are on the top stocks and click on them to go out their web site
  7. Click on the stock/company to go to their yahoo finance page
  8. Go over the winners circle and check out which newsletters choose the top penny stocks (this page will show you all of the past winners and which newsletters choose them)
  9. The Ring Side Judges forums gives you a open forum to discuss all things penny stocks
  10. Twitter Feed: get the latest feed on who the winner of the day is.
  11. Google Business News Feed
  12. Friend us on facebook, follow us on twitter and send us an email with any comments for questions
This is truly a revolutionary trading tool. Never before has a web site consolidated all the stock picks of the day and displayed them side by side in one location on the web.

About Aastrom Biosciences, Inc. (ASTM):
Aastrom Biosciences, Inc., a regenerative medicine company, engages in developing autologous cell therapies for the treatment of severe and chronic cardiovascular diseases.

No comments:

Post a Comment